Consolidated Statements of Shareholders’ Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2018	$ 1,928,504	$ (5,549)	$ 7	$ 371,225		$ (67,016)	$ 1,625,481	$ (5,549)	$ (1,193)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	8,154			8,154
Repurchase of common stock	(5,439)					(5,439)
Proceeds from options exercised	1			1
Changes in comprehensive income	406								406
Net income (loss)	335,255						335,255
Ending balance at Dec. 31, 2019	$ 2,261,332	(1,609)	7	379,380		(72,455)	1,955,187	(1,609)	(787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
Share-based compensation	$ 11,575			11,575
Repurchase of common stock	(1,669)					(1,669)
Proceeds from options exercised	39			39
Changes in comprehensive income	169								169
Issuance of common stock and warrants, net	352,968		3	352,965
Equity component value of convertible debt issuance, net	55,590			55,590
Net income (loss)	(428,700)						(428,700)
Ending balance at Dec. 31, 2020	$ 2,249,695	$ (49,530)	10	799,549	$ (55,590)	(74,124)	1,524,878	$ 6,060	(618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06
Share-based compensation	$ 12,536			12,536
Repurchase of common stock	(1,515)					(1,515)
Changes in comprehensive income	86								86
Issuance of common stock and warrants, net	375,332		1	375,331
Net income (loss)	(472,569)						(472,569)
Ending balance at Dec. 31, 2021	$ 2,114,035		$ 11	$ 1,131,826		$ (75,639)	$ 1,058,369		$ (532)